By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Swedish Orphan AB 

Stureplan 15

Stockholm    S-11145  Sweden
Phone: n/a Fax: n/a



Company News
Swedish Orphan AB - Elocta Approved In The Kingdom Of Saudi Arabia For The Treatment Of Haemophilia A 5/18/2017 6:33:50 AM
Swedish Orphan AB - FDA Approves In-Use Storage At Room Temperature For Orfadin Capsules 3/7/2017 6:57:37 AM
Swedish Orphan AB Publishes Its Report For The Fourth Quarter And Full Year 2014 2/19/2015 1:09:53 PM
Auxilium Pharmaceuticals (AUXL) Release: Swedish Orphan AB Files For EU Approval Of Xiapex For Peyronies Disease 6/25/2014 6:50:14 AM
Biogen Idec, Inc. (Massachusetts) (BIIB) and Swedish Orphan Biovitrum Present New Data From the Phase 3 Study of Their Long-Lasting Hemophilia Factor Candidate ELOCTATE™ 7/8/2013 10:45:53 AM
Swedish Orphan Biovitrum Gets FDA Approval to Manufacture Substance for Kineret® With Partner Boehringer Ingelheim Corporation 6/11/2013 9:48:34 AM
Swedish Orphan Biovitrum Appoints Mats-Olof Wallin as Permanent Chief Financial Officer 5/17/2013 10:20:28 AM
Swedish Orphan Biovitrum Appoints Mats-Olof Wallin as Interim Chief Financial Officer 4/8/2013 9:20:07 AM
Swedish Orphan Biovitrum Publishes Annual Report 4/5/2013 9:20:44 AM
Swedish Orphan Biovitrum Gains Distribution Rights for Megace®, Monopril®, Cefzil®; and Duricef®; From PharmaSwiss 2/13/2013 10:00:36 AM